Adjuvant icotinib for resected EGFR-mutated stage II–IIIA non-small-cell lung cancer (ICTAN, GASTO1002): a randomized comparison study

ABSTRACT:

SUBMITTER: Li N 

PROVIDER: S-EPMC12391381 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature